Beris_Table-1

Genetic modificated, with chimeric antigen receptor, T lymphocytes therapies in hematological malignancies

Haema 2016; 7(1): 27-36

by Panagiotis Kaloyannidis

Haematology Clinic – Bone Marrow Transplantation Unit, Gene and Cell Therapy Center “G. Papanikolaou” General Hospital, Thessaloniki, Greece

Full PDF (in Greek) |

Continue reading “Genetic modificated, with chimeric antigen receptor, T lymphocytes therapies in hematological malignancies”

Beris_Table-1

The development of gene therapy

Haema 2016; 7(1): 45-56

by Evangelia Yiannaki1,2, Varnavas Constantinou1, George Stamatoyannopoulos2

1Gene and Cell Therapy Center, Haematology Department and Bone Marrow Transplantation Unit, “G. Papanikolaou” Hospital, Thessaloniki, Greece,
2Department of Medicine and Markey Molecular Medicine Center, University of Washington, Seattle, WA, USA

Full PDF (in Greek) |

Continue reading “The development of gene therapy”

Beris_Table-1

Gene and cell therapy for beta-thalassemia and sickle cell disease with induced pluripotent stem cells (iPSCs): the next frontier

Haema 2016; 7(1): 100-110

by Eirini P. Papapetrou

Departments of Oncological Sciences, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Full PDF (in Greek) |

Continue reading “Gene and cell therapy for beta-thalassemia and sickle cell disease with induced pluripotent stem cells (iPSCs): the next frontier”